The Hilb Group, LLC Acquires Book of Business and Hires Julie Paton
RICHMOND, Va., March 24, 2020 /PRNewswire/ -- The Hilb Group, LLC ("THG") announced today that it has acquired Healthcare Liability Consultants Agency, Inc. and hired owner and medical malpractice insurance specialist, Julie Paton, as a producer. The transaction became effective March 1, 2020.
Based in Cleveland, Ohio, Paton will join the THG's Central/Midwest operations and continue to provide customized solutions to her clients. Her addition will complement and strengthen THG's medical malpractice capabilities in the Central region.
About THG: THG is a leading middle market insurance agency headquartered in Richmond, Virginia and is a portfolio company of global investment firm, The Carlyle Group. THG seeks to grow through targeted acquisitions in the middle market insurance brokerage space. The company now has over 90 offices in 20 states. Please visit our website at: http://hilbgroup.com.
Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until May 17, 2024 to file lead plaintiff applications in a securities class action lawsuit against SSR Mining...
Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until May 21, 2024 to file lead plaintiff applications in a securities class action lawsuit against Shoals...
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Lincoln National Corporation ("Lincoln National" or "the Company") and certain of its...
TSX VENTURE COMPANIES
BULLETIN V2024-1211
ALPHAMIN RESOURCES CORP. ("AFM")BULLETIN TYPE: Declaration of DividendBULLETIN DATE: April 26, 2024TSX Venture Tier 2 Company
The Issuer has declared the following dividend:
Dividend Amount per Common...
Wall Financial Corporation (the "Company") released its operating results and financial statements for the three months and year ended January 31, 2024. The Company recorded net earnings and comprehensive income attributable to shareholders of the...
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...
